Journal for ImmunoTherapy of Cancer (Nov 2023)

614 Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study

  • Bhumsuk Keam,
  • Chan-Young Ock,
  • Do-Youn Oh,
  • Seung-Tae Kim,
  • Keun-Wook Lee,
  • Sun Young Rha,
  • Changhoon Yoo,
  • John Park,
  • Min Hwan Kim,
  • Sehyun Kim,
  • Dhanusha Sabanathan,
  • Joon Oh Park,
  • Napa Parinyanitikul,
  • Kyu Pyo Kim,
  • Jaebong Yoon,
  • Hyelim Lim,
  • Sangheon Lee,
  • Wooick Jang

DOI
https://doi.org/10.1136/jitc-2023-SITC2023.0614
Journal volume & issue
Vol. 11, no. Suppl 1

Abstract

Read online

No abstracts available.